PRIDE REGISTRY Trademark

Trademark Overview

On Saturday, February 25, 2012, a trademark application was filed for PRIDE REGISTRY with the United States Patent and Trademark Office. The USPTO has given the PRIDE REGISTRY trademark a serial number of 85552871. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, July 31, 2020. This trademark is owned by Natural Molecular Testing Corporation. The PRIDE REGISTRY trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Maintaining and providing an online database of medical and scientific research information concerning patient drug interaction data, genome-based drug dosing and interaction with other environmental and patient factors
pride registry

General Information

Serial Number85552871
Word MarkPRIDE REGISTRY
Filing DateSaturday, February 25, 2012
Status710 - CANCELLED - SECTION 8
Status DateFriday, July 31, 2020
Registration Number4455684
Registration DateTuesday, December 24, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 29, 2013

Trademark Statements

Disclaimer with Predetermined Text"REGISTRY"
Goods and ServicesMaintaining and providing an online database of medical and scientific research information concerning patient drug interaction data, genome-based drug dosing and interaction with other environmental and patient factors

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, July 31, 2020
Primary Code042
First Use Anywhere DateTuesday, May 1, 2012
First Use In Commerce DateSaturday, September 1, 2012

Trademark Owner History

Party NameNatural Molecular Testing Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRenton, WA 98057
Party NameNatural Molecular Testing Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRenton, WA 98057
Party NameNatural Molecular Testing Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRenton, WA 98057

Trademark Events

Event DateEvent Description
Friday, July 31, 2020CANCELLED SEC. 8 (6-YR)
Monday, December 24, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, December 24, 2013REGISTERED-PRINCIPAL REGISTER
Friday, November 22, 2013NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, November 21, 2013LAW OFFICE REGISTRATION REVIEW COMPLETED
Wednesday, November 20, 2013ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, October 31, 2013STATEMENT OF USE PROCESSING COMPLETE
Thursday, September 26, 2013USE AMENDMENT FILED
Friday, October 25, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, September 26, 2013TEAS STATEMENT OF USE RECEIVED
Tuesday, March 26, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, February 28, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 29, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 29, 2013PUBLISHED FOR OPPOSITION
Wednesday, January 9, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, December 27, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, December 27, 2012ASSIGNED TO LIE
Monday, December 10, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, December 10, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 10, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 10, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, June 8, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, June 8, 2012NON-FINAL ACTION E-MAILED
Friday, June 8, 2012NON-FINAL ACTION WRITTEN
Wednesday, June 6, 2012ASSIGNED TO EXAMINER
Monday, March 5, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Wednesday, February 29, 2012NEW APPLICATION ENTERED IN TRAM

Related Keywords

registry pride interaction drug patient based genome data dosing other factors environmental